Routine use of whole-cell pertussis vaccines was suspended in some countries in the 1970s/1980s because of concerns about adverse effects. There was a resurgence of whooping cough. Acellular pertussis vaccines (containing purified or recombinant Bordetella pertussis antigens) were developed in the hope that they would be as effective but less reactogenic than the whole-cell vaccines.
CITATION STYLE
Zhang, L., Prietsch, S. O., Axelsson, I., & Halperin, S. A. (2012). Acellular vaccines for preventing whooping cough in children. In Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. https://doi.org/10.1002/14651858.cd001478.pub5
Mendeley helps you to discover research relevant for your work.